The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform — INSPIRE  

Biological Aging Clinical Trial

Official title: The Inspire Bio-resource Research Platform for Healthy Aging

Status Recruiting

Clinical Trial Summary

Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.

Clinical Trial Description

This is a 10-year observational study. The study will be performed in Occitania Region. Once a year, a complete data collection will be performed in the Gerontopole of Toulouse, in participants' home and health centers by the Gerontopole mobile research team, and in selected Gerontopole's collaborating centers in Occitania.

Between yearly waves of data collection, participants will have their intrinsic capacity domains monitored (with or without the help of a caregiver) each 4-month through the use of either an app developed in collaboration with World Health Organization (WHO) or a web platform; or through a phone call by a clinical/research nurse. For the first self-monitoring of IC at four months, all participants will be contacted by a research/clinical nurse by phone; this call will inform about how participants measured their capacity and/or help them to do it. After this first 4-month phone call, participants capable of correctly self-monitoring their IC through the app will no longer be systematically contacted by phone. Once IC declines are confirmed, participants will have a thorough clinical assessment and blood sampling; such information will allow us to investigate the response of markers of aging at the time declines are detected. Those needing usual care, will be followed according to WHO framework recommendations proposed for Integrated Care for Older Adults (ICOPE). ;

Related Conditions & MeSH terms

• Biological Aging

• NCT number: NCT04224038
• Study type: Observational [Patient Registry]
• Source: University Hospital, Toulouse
• Contact: Bruno VELLAS, MD
• Phone: 5 61 77 70 47
• Email: vellas.b@chu-toulouse.fr
• Status: Recruiting
• Start date: October 16, 2019
• Completion date: October 31, 2033